No Major Concerns Raised By FDA Staff On Grail's Galleri Multicancer Blood Test

No Major Concerns Raised By FDA Staff On Grail's Galleri Multicancer Blood Test Shares of Grail surged as FDA briefing documents were released ahead of an advisers' meeting Wednesday on the Galleri multicancer early detection blood test, MedPage Today and Stat reported. https://kffhealthnews.org/morning-breakout/pharma-and-tech-092226/